Hyalinizing Trabecular Tumor of the Thyroid: An Update
- 281 Downloads
Hyalinizing trabecular tumor (HTT) is a rare thyroid tumor of follicular cell origin with a trabecular pattern of growth and marked intratrabecular hyalinization. This tumor is known to share morphological and architectural similarities with paraganglioma and medullary thyroid carcinoma, as well as the nuclear features and RET/PTC1 translocations of papillary thyroid carcinoma. These tumors are not associated with RAS or BRAF mutations. Whether the presence of RET alterations in HTT are sufficient molecular proof of its relationship with papillary thyroid carcinoma (PTC) is still to be defined. Of great interest is the characteristic strong peripheral cytoplasmic and membranous staining of the tumor cells with MIB1 immunostain, not seen in any other thyroid neoplasm. Although cases of malignant HTT have been recorded, HTT should be considered a benign neoplasm or, at most, a neoplasm of extremely low malignant potential.
Keywordshyalinizing trabecular tumor hyalinizing trabecular adenoma thyroid papillary carcinoma BRAF RET/PTC
- 3.DeLellis RA, Lloyd R, Heitz PU, Eng C, editors. WHO Classification of Tumors. Pathology and Genetics—Tumors of Endocrine Organs, IARC Press, Lyon, pp 104–105, 2004.Google Scholar
- 15.Rothemberg HJ, Goellner JR, Carney JA. Prevalence and incidence of cytoplasmic yellow bodies in thyroid neoplasms. Arch Pathol Lab Med 127(6):715–7, 2003.Google Scholar
- 32.Salvatore G, Chiappetta G, Nikiforov YE, Decaussin-Petrucci M, Fusco A, Carney JA, Santoro M. Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer 41:816–21, 2005.PubMedCrossRefGoogle Scholar
- 34.Chiappetta G, Toti P, Cetta F, Giuliano A, Pentimalli F, Amendola I, Lazzi S, Monaco M, Mazzuchelli L, Tosi P, Santoro M, Fusco A. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthlecell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol Metab 87:364–9, 2002.PubMedCrossRefGoogle Scholar